NIH-funded research R01 grant

Understanding How CRISPR-Cas9 Gene Editing Works

Official title: Investigating the metal-dependent function, allostery and inhibition of CRISPR-Cas9

Funded at University of California Riverside · NIH-11365161 · Data updated 2026-11-12

This project aims to understand the tiny details of how CRISPR-Cas9 gene editing works to help make it better and safer for treating human diseases.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California Riverside
NIH-funded
Lab location1 site (Riverside, United States)
Project startApril 1, 2021
Project endMarch 31, 2027
Funding year2025
Award (this year)$85,191
NIH project number3R01GM141329-05S1
Project IDNIH-11365161 on NIH RePORTER

Who could benefit from this research

Could help

Patients who might benefit from future gene-editing therapies for genetic diseases are the ultimate focus of this foundational work.

Less likely to help

Patients will not directly participate in or receive immediate benefit from this fundamental laboratory research.

What this research studies

This project dives deep into the fundamental workings of CRISPR-Cas9, a powerful gene-editing tool that holds great promise for treating many human genetic diseases. We are exploring how this tool uses different metal ions to cut DNA and how its internal controls (allostery) help it target specific genes more accurately. We also want to understand how natural inhibitors can stop CRISPR-Cas9, which could help us control its activity better. By understanding these tiny details, we hope to make gene editing safer and more precise for future treatments.

Why it matters

Potential benefit: Success in this area could lead to more precise and controllable CRISPR-Cas9 gene editing tools, making future gene therapies safer and more effective for a wide range of genetic conditions.

How similar studies have gone: CRISPR-Cas9 technology has shown success in initial applications, but this project explores novel, detailed mechanisms to enhance its precision and control.

Where this research is happening

  • University of California Riverside
    Riverside, United States
    Active

Researchers

  • Principal investigator: Palermo, Giulia — University of California Riverside
  • Study coordinator: Palermo, Giulia

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.